Skip to main content
. 2021 Apr 5;112(6):2393–2404. doi: 10.1111/cas.14883

FIGURE 6.

FIGURE 6

Construction and validation of the diagnostic model based on the 3 miRNAs in the qPCR validation cohort. A, ROC curves of the 3 miRNA (miR‐134‐5p, miR‐205‐5p, miR‐409‐3p)‐based model in the training and validation sets. B, ROC curves for the diagnosis of patients with NPC using the 3 miRNA‐based model in the subgroup analysis. Risk probability distribution plots and heatmap of the 3 miRNAs in the training set (C), and validation set (D), NPC, nasopharyngeal carcinoma; HC, healthy control; EB, patients with NPC positive for Epstein‐Barr virus infection; NEB, patients with NPC negative for Epstein‐Barr virus infection; Early, patients with NPC diagnosed at an early stage; Advanced, patients with NPC diagnosed at an advanced stage